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Abstract A woman goes through many biological (hormonal, physical), psychological (emotional), and 
socio-cultural changes during pregnancy. Furthermore, changes also occur in the mother's 
familial and interpersonal world after childbirth. While some mothers have positive emotions at 
birth, such as joy and pleasure, others complain of negative experiences varying from sadness 
and depression to psychosis. Thus, the risk of depression is higher for women during the 
postpartum period, having a tendency to decrease in most cases over the first 2 weeks after 
delivery. Unfortunately, this favorable evolution does not happen in about 1 in 4-7 women, who 
develops postpartum depression. Postpartum depression has generally the same features as any 
common depressive episode encountered at any other time in life. However, assessment of 
depressive symptoms in the parental period implies not only general tools (such as the Depression 
Scale of the Center for Epidemiological Studies or the Beck Depression Inventory), but also a 
specific evaluation using the Edinburgh Postnatal Depression Scale. Taking into account all 
changes that occur during the peripartum period, a multimodal approach for postpartum 
depression would be recommended, including an appropriate lifestyle (walks, ambient 
environments), counseling, cognitive-behavioral therapy, and finally antidepressant medication 
when required. As a conclusion, postpartum depression may range from a mild and reversible 
episode to a severe and persistent form. Antepartum and postpartum screening, an early diagnosis, 
and a tailored approach to depression are essential for better results and prognosis related to both 
mother and child.   
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Highlights ✓ Postpartum depression has multiple implications, not only on the mother (behavior) but 
also on the child (mental development). 
✓ Early diagnosis and appropriate therapeutic approach/ psychological counseling are key 
factors for good postpartum depression management.       
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Introduction 
The diagnosis of depression is generally three times 
greater in women than in men. In addition, depression 
seems to affect the person's functioning to a greater 
extent in women. The World Health Organization 
(WHO) considers that about a quarter of women suffer 
from an affective disorder throughout their lives. The 
vulnerability to depression increases in women mostly 
during childbearing age (15-44 years), such a disorder 
often associating with hormonal and psychosocial 
factors/ imbalances (1). In women depression may also 
occur when breast cancer is diagnosed and/ or after 
breast cancer surgery (2), as well as in close relation 
with type of birth (3) or after serious complications 
during cesarean surgery (4). 
A vulnerable period for the occurrence of 
depression in women is the postpartum period, up to 
85% of women being placed in circumstances that lead 
to the experience of different levels of affective 
disorders during this stage. As an example, the 
American Academy of Pediatrics (AAP) estimates that 
more than 400,000 children are born each year to 
depressed mothers. 
Postpartum affective disorders are classified 
according to their intensity in: 
• Postpartum sadness (baby blues or maternity blues), 
with onset in the first 2 postpartum weeks. Baby Blues 
is a term used to describe worry, fear, and unhappiness 
or fatigue, feelings through which many women pass 
after birth. Baby Blues affects up to 80% of mothers and 
lasts for 1-2 weeks, having a mild intensity.     
• Postpartum depression, which can stretch over a 
longer period of time, from 1 to 12 months after the 
birth. 
• Puerperal psychosis (in the immediate after-birth 
period), which presents an acute onset during the first 3-
4 weeks postpartum (5).    
Generally, symptoms of affective disorders are for 
most women transient (postpartum blues), but up to 10-
15% of women may experience persistent symptoms of 
depression and 0.1-0.2% may develop severe 
postpartum depression associated with psychosis (6).   
Discussions 
Postpartum depression is defined as the occurrence 
of a mild/ moderate non-psychotic depressive episode, 
with onset from the first postnatal month to 1 year. It is 
more common in developed countries, raising a major 
public health problem, due to the negative effects on the 
mother and the child (especially in terms of the child’s 
development), but also on the marriage relationship and 
even social relationships. Postpartum depression is 
characterized by psychological, physical, and emotional 
changes that occur in women after birth. Its diagnosis is 
based on the time interval between birth and onset of the 
condition, but also on the severity of the depression (7). 
Postpartum depression has common features with a 
depressive episode that occurs at any other time in life: 
irritability, anxiety, feelings of loneliness, fear of 
madness, and loss of self. Women with postnatal 
depression show increased anxiety and are self-
perceived as incapacitating and unbearable mothers (8). 
Postpartum depression may occur de novo in normally 
mentally healthy women, or build on the background of 
small pre-existing psycho-emotional disorders, or 
continue a prenatal deep sadness (inapetence, loss of 
interest, trouble sleeping and eating, etc.).  
Depression is also more common in people/ women 
with risk factors. Certain hormonal, biological, and 
psychosocial factors are considered risk factors for 
postpartum affective disorders. In postpartum 
depression, extreme feelings such as sadness and 
anxiety predominate, making the mother feel unable to 
care for her, her family, and especially her child (9). 
Regarding postpartum depression, hormonal factors are 
represented by the decrease of estrogen, progesterone, 
and cortisol concentration in blood, changes that occur 
in the first 48 hours after delivery. Affected/ susceptible 
women may be abnormally sensitive to hormonal 
variations, and may develop symptoms of depression. 
Recent data indicate that premenstrual dysphoric 
syndrome is a risk factor for postpartum major 
depressive disorder (10). It is well known that during 
pregnancy, estrogen and progesterone blood levels are 
10 times higher than usual. Their sudden drop after 
delivery appears to be related to postpartum depression, 
this association being not yet fully understood. 
Postpartum and even perinatal (including both 
postpartum and prenatal) depression has also been 
associated with low levels of oxytocin (11). 
Recent studies indicate that there are complex 
associations between immunity and depression. One 
such study, starting from the observation that 
postpartum depression is more common than depression 
during pregnancy, was performed on a sample of 51 
women.  During the study, mood and anxiety level were 
assessed, as well as 23 cytokines, 5 times during 
pregnancy and postpartum. An increase in pro-
inflammatory markers occurs during the peripartum 
period in patients with depressive or anxious symptoms. 
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The results indicate, in mentally ill women, increased 
activation of the immune response occurring towards the 
end of pregnancy (12). Another study performed at 
Brazil State Maternity from 2015 to 2017 on a sample 
of 168 patients, with 40 women with hypertensive 
disorders of pregnancy (HDP) and 126 normotensive 
ones, found that women diagnosed with HDP had more 
depressive symptoms than their normotensive 
counterparts (13).   
The first pregnancy is at increased risk of 
peripartum depression, which is explained at least in part 
by the mother's lack of experience. A decrease in the 
incidence of parental depression has been reported in 
couples who attended parenting courses before the birth 
of the first child (14). 
Besides clinical symptoms and laboratory data 
(although the term postpartum depression officially 
entered the medical literature in 1950), so far only 17 
imaging studies of the brain have been performed to 
investigate postpartum depression (15).  
Psychological risk factors are associated with a 
history of personal depression, anxiety or depression in 
pregnancy, low social support, or recent negative impact 
events such as a family member death, financial 
difficulties, or partner violence. Also, women with a 
history of postpartum depression or psychosis have a 
recurrence risk of up to 90% (16).   
Biological vulnerability is associated with a 
personal history of depression, family history of 
behavioral disorders, or depression during pregnancy, 
these women having a higher risk of developing 
postpartum depression. Apparently, there is no 
conclusive association between obstetrical factors and 
the risk of postpartum depression. 
Risk factors are classified based on their effects, as 
shown in Table 1. 
Postpartum depression is diagnosed when at least 5 
of the following symptoms (and at least one of the first 
two) are present, with a duration of at least 2 weeks (17). 
1. Depressive mood, sadness, feelings of despair and 
inner void, associated with a state of severe anxiety; 
2. Loss of interest in daily activities; 
3. Changes in appetite and weight (usually 
decreasing); 
4. Changes in sleep (usually insomnia); 
5. Changes in attitude and speech (restlessness, 
apathy); 
6. Extreme fatigue or lack of energy; 
7. Feelings of futility or guilt; 
8. Difficulties in maintaining concentration or 
decision making; 
9. Suicidal thoughts. 
Table 1. Risk factors classification for postpartum 
depression 
Sociodemographic 
factors with 
insignificant effect 
- the mother's age and 
educational level 
- parity 
- ethnicity 
- gender 
Low-risk factors - complications in 
pregnancy 
- socio-economic status 
Moderate risk factors - low self-esteem 
- marital relationship 
- difficult temperament 
of the child 
- increased stress level 
related to child care 
Moderate-strong risk 
factors 
- depression / anxiety 
in pregnancy 
- personal history of 
prepregnancy-related 
depression 
- low social status 
Depressive symptoms in the perinatal period can be 
measured using specific instruments such as the  
Edinburgh Postnatal Depression Scale  (EPDS), and/ or 
general tools such as the Depression Scale of the Center 
for Epidemiological Studies (CES-D) or the Beck 
Depression Inventory scale (6). The Edinburgh 
Postnatal Depression Scale (EPDS) contains 10 
questions for assessing the risk of depression during and 
after pregnancy, with a score between 0 and 3. Scores 
higher than 13 correspond to high level of symptoms (7). 
The EPDS not only assesses the risk of postpartum 
depression, but also correlates with breastfeeding, the 
effects on the father, the type of birth, and its influence 
on the mental condition, especially in association with 
other predictive scales. Using this assessment 
instrument and a breastfeeding self-efficacy scale, a 
cohort study of 83 patients demonstrated that 
postpartum depression is a major risk factor for 
discontinuation of breastfeeding (18). 
Depression can affect not only women but also men 
when they become parents, and this psycho-social factor 
can induce/ increase in turn the postpartum depression 
of the mother. Men may feel sadness, fatigue, anxiety, 
and perceive changes in their usual habits. Symptoms 
are similar to those seen in postpartum women, or to 
depression in general. A risk category for fathers with 
depression is young men and those who face financial or 
couple problems. Sometimes called paternal depression, 
Anca Daniela Stanescu et al. 
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this affection can have the same effects on the child and 
the couple's relationship as postpartum depression. One 
study conducted on a sample of 298 spouses of pregnant 
women who gave birth by caesarean section to 
Zonguldak Maternity (the data being collected using 
Edinburgh Postnatal Depression Scale) showed that 
more than one-third of fathers were at risk for 
postpartum depression. The study concluded that the 
risk of postpartum depression is high for fathers having 
a female newborn, or having a spouse with postpartum 
depression.   
Noting that in the UK about 92,000 women give 
birth annually via elective cesarean section, a study was 
conducted (between 2015 and 2016 at Wales Hospital 
University) to determine the prevalence of depression 
and anxiety using specific assessment questionnaires 
and the Edinburgh Scale. Women with prenatal anxiety 
who gave birth by elective cesarean section showed 
ongoing symptoms more than a year after delivery (19).  
Another cohort study performed at 2 and 6 months 
postpartum included 513 questionnaires reporting on 
three scales: the Karitane Parenting Confidence Scale 
(KPCS), the Edinburgh Postnatal Depression Scale 
(EPDS), and the Parental Stress Scale (PSS). This study 
demonstrated that KPCS scores at 2 months postpartum 
were the strongest predictors for both maternal and 
parental stress, symptoms that generally involved the 
underlying symptoms of postpartum depression (20). 
Postpartum depression acts on both the mother and 
the child. The child may show a delay in developing 
mental and behavioral abilities, such that an early 
therapeutic approach toward postpartum depression is 
recommended. This strategy has been associated with a 
better prognosis, therapeutic options being carefully 
adapted to the severity of the disease. Failure or 
inappropriate treatment can lead to a deterioration of the 
relationship between the mother and child or between 
mother and her partner. It may also increase the risk of 
morbidity in both the mother and child (21). 
Although several studies have sought ways to 
prevent postpartum depression, no specific factor for 
triggering postpartum depression has been identified. As 
a consequence, therapeutic options for postpartum 
depression are multiple and typically include some form 
of a multimodal therapy, as presented below. 
Cognitive-behavioral therapy  
When applied by a trained counselor, studies have 
shown that symptoms of postpartum depression 
decrease after the first session and show significant 
relief after six sessions (22). 
Antidepressant medication 
The use of antidepressants that have no adverse 
effects on the child are recommended so as to avoid the 
need to stop breastfeeding. Whether or not 
breastfeeding, treatment with serotonin reuptake 
inhibitors (SSRI) is recommended, due to the fact that 
this class of drugs is highly effectiveand presents 
mininimal side effects for women with postnatal 
depression (23). 
Women treated with valproic acid or 
carbamazepine should avoid breastfeeding as these 
medications can cause liver toxicity in the baby. Also, 
breast-feeding should be avoided in premature or 
hepatically impaired children due to the difficulty of 
metabolizing these agents contained in mother’s milk 
(24). 
Antidepressant medication used to treat postpartum 
depression can also treat symptoms such as insomnia, 
inappetence, and exhaustion but may not bring relief 
from negative thought patterns that cause/ maintain 
depression. For this reason, the Canadian Mental Health 
Organization recommends combining medication with 
psychological counseling (25). 
Other recommendations that have proven useful for 
postpartum depression are walking or moderate 
exercise, family or friends visits, ambient lighting, and 
a balanced diet with avoidance of coffee and alcohol 
consumption. Daily exercise and avoiding overwork, 
good sleep, and rest have documented benefits. 
Interacting with others who also suffer from the problem 
is recommended, along with music therapy. 
Aromatherapy may help prevent the occurrence of 
postpartum depression and may also be an adjuvant 
treatment for it (26).  
High cholesterol levels during postpartum may 
contribute to protecting the mother's psychological state 
(27). Finally, there is no link between HIV-positive 
pregnant women receiving antiretroviral therapy and 
postpartum depression (28). 
Conclusions 
Perinatal mental illness, including pospartum 
depression, is generally under-diagnosed. Postpartum 
depression may range from a mild and reversible 
episode (with a tendency to decrease in most cases over 
the first 2 weeks after delivery) to severe and persistent 
forms that require adequate/ multimodal therapeutic 
support.  
Postpartum depression. 
167 
Healthcare professionals should regularly evaluate 
women during antepartum and postpartum periods, 
using general and specific tools (Depression Scale of the 
Center for Epidemiological Studies, the Beck 
Depression Inventory, the Edinburgh Postnatal 
Depression Scale). Women who are at high-risk for 
developing postpartum depression should be identified 
and carefully monitored. An early diagnosis of 
postpartum depression allows a precoce and tailored 
approach for the condition, both of which are essential 
for optimal results related to mental and physical 
evolution of mother and child(s). 
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